Newton, MA, United States of America

Pushkal Garg

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.8

ph-index = 1


Location History:

  • Newton, MA (US) (2021)
  • Cambridge, MA (US) (2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pushkal Garg: Innovator in RNA Therapeutics

Introduction

Pushkal Garg is a notable inventor based in Newton, MA, who has made significant contributions to the field of RNA therapeutics. With a total of two patents to his name, Garg's work focuses on innovative methods and compositions that address critical medical challenges.

Latest Patents

Garg's latest patents include the Tunable Reversir™ compounds, which relate to agents that modulate the pharmacological activity of siRNAs. This invention also encompasses methods and systems for assessing the efficacy and safety of pharmaceutical compositions aimed at treating or preventing diseases. Another significant patent involves methods and compositions for treating Serpinc1-associated disorders. This invention targets the Serpinc1 gene using double-stranded ribonucleic acid (dsRNA) to inhibit its expression, providing potential treatments for bleeding disorders such as hemophilia.

Career Highlights

Throughout his career, Pushkal Garg has worked with prominent companies in the biotechnology sector, including Alnylam Pharmaceuticals, Inc. and Genzyme Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas in RNA-based therapies.

Collaborations

Garg has collaborated with talented individuals in his field, including coworkers Ivan Zlatev and Adam Castoreno. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Pushkal Garg's contributions to RNA therapeutics through his innovative patents and collaborations highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in treatments for serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…